“As you talk to [female] colleagues in the world, they all kind of nod their head. ‘I’ve been told that,’” Bhatia said. “It’s sort of like: Note to self.”
Women have made significant gains in the sciences during the past few decades, but men continue to dominate leadership of the biotech industry — where science and business collide to turn ivory tower insights into medicines and biomedical technologies that can change the world. It’s a disparity hidden in plain sight, from the predominantly male chief executives of biotech companies to, as Bloomberg News reported, a party at the biggest dealmaking event of the year that featured models in tiny dresses as cocktail waitresses.